Varithena injectable foam 45ML
Ended Awarded
- Contract number
- SPE2DB26FH4TN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,612
Award facts
- Contract value 100% obligated
- $9,612.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $9,612.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Varithena Injectable Foam 45ML. The award, issued on October 28, 2025, with an ultimate completion date of November 19, 2025, utilizes firm fixed-price pricing with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical supply support to Department of Defense military healthcare facilities worldwide.
DMS Pharmaceutical Group has demonstrated substantial performance as a critical supplier within the federal pharmaceutical supply chain, supporting the DLA's Medical Supply Chain division with numerous delivery orders spanning diverse therapeutic categories including oncology treatments, biologics, vaccines, specialty pharmaceuticals, and medical consumables. The company's single-award IDC under PPV-G GEN V, designated contract SPE2DR and valued at $499,999,999 through December 31, 2036, positions it as a regional prime vendor contractor capable of fulfilling the specialized pharmaceutical requirements of military healthcare operations globally. The current delivery order for Varithena Injectable Foam represents routine execution of this broader contract vehicle supporting ongoing DoD medical supply needs.
Quick answers
Who was awarded contract SPE2DB26FH4TN?
SPE2DB26FH4TN was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DB26FH4TN worth?
The government has obligated $9,612 on SPE2DB26FH4TN.
Is contract SPE2DB26FH4TN an order under another contract?
Yes. SPE2DB26FH4TN is a delivery order under SPE2DB22D9207, an indefinite delivery contract.
Was contract SPE2DB26FH4TN competed?
The extent of competition for SPE2DB26FH4TN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award